Recent advances in the molecular pathophysiology of atrial fibrillation.

Atrial fibrillation (AF) is an extremely common cardiac rhythm disorder that causes substantial morbidity and contributes to mortality. The mechanisms underlying AF are complex, involving both increased spontaneous ectopic firing of atrial cells and impulse reentry through atrial tissue. Over the past ten years, there has been enormous progress in understanding the underlying molecular pathobiology. This article reviews the basic mechanisms and molecular processes causing AF. We discuss the ways in which cardiac disease states, extracardiac factors, and abnormal genetic control lead to the arrhythmia. We conclude with a discussion of the potential therapeutic implications that might arise from an improved mechanistic understanding.

[1]  R Fischmeister,et al.  Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. , 1993, The Journal of biological chemistry.

[2]  C. Antzelevitch,et al.  Atrial fibrillation and Brugada syndrome. , 2008, Journal of the American College of Cardiology.

[3]  Y. Shibamoto,et al.  The ZFHX3 (ATBF1) transcription factor induces PDGFRB, which activates ATM in the cytoplasm to protect cerebellar neurons from oxidative stress , 2010, Disease Models & Mechanisms.

[4]  A. Zima,et al.  Endothelin-1–Induced Arrhythmogenic Ca2+ Signaling Is Abolished in Atrial Myocytes of Inositol-1,4,5-Trisphosphate(IP3)–Receptor Type 2–Deficient Mice , 2005, Circulation research.

[5]  Eric E. Smith,et al.  Variants conferring risk of atrial fibrillation on chromosome 4q25 , 2007, Nature.

[6]  Stanley Nattel,et al.  Characterization of a hyperpolarization‐activated time‐dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium , 2004, The Journal of physiology.

[7]  Delon Wu,et al.  Intracellular calcium dynamics and acetylcholine-induced triggered activity in the pulmonary veins of dogs with pacing-induced heart failure. , 2008, Heart rhythm.

[8]  Da-Zhi Wang,et al.  The Emerging Role of MicroRNAs as a Therapeutic Target for Cardiovascular Disease , 2010, BioDrugs.

[9]  M. Chung,et al.  Atrial Glutathione Content, Calcium Current, and Contractility* , 2007, Journal of Biological Chemistry.

[10]  M. Rienstra,et al.  Monogenic atrial fibrillation as pathophysiological paradigms. , 2011, Cardiovascular research.

[11]  C. McGann,et al.  MRI of the left atrium: predicting clinical outcomes in patients with atrial fibrillation , 2011, Expert review of cardiovascular therapy.

[12]  Ning Wang,et al.  MicroRNA-328 Contributes to Adverse Electrical Remodeling in Atrial Fibrillation , 2010, Circulation.

[13]  G. Breithardt,et al.  Atrial Arrhythmias in Long‐QT Syndrome under Daily Life Conditions: A Nested Case Control Study , 2009, Journal of cardiovascular electrophysiology.

[14]  Nolwenn Le Meur,et al.  Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man. , 2006, Journal of molecular and cellular cardiology.

[15]  Stanley Nattel,et al.  Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications , 2008, Circulation. Arrhythmia and electrophysiology.

[16]  Ping Zhang,et al.  Inositol-1,4,5-Trisphosphate and Ryanodine-Dependent Ca2+ Signaling in a Chronic Dog Model of Atrial Fibrillation , 2006, Cardiology.

[17]  X. Wehrens,et al.  Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. , 2008, Heart rhythm.

[18]  J. Auer,et al.  Subclinical hyperthyroidism as a risk factor for atrial fibrillation. , 2001, American heart journal.

[19]  S. Nattel,et al.  Abstract 1343: Atrial Cardiomyocyte Tachycardia Alters Cardiac Fibroblast Function: A Novel Consideration in Atrial Remodeling , 2007 .

[20]  E. Niggli,et al.  Increased Ca2+ leak and spatiotemporal coherence of Ca2+ release in cardiomyocytes during β‐adrenergic stimulation , 2010, The Journal of physiology.

[21]  R. Duisters,et al.  MIRNA-133 AND MIRNA-30 REGULATE CONNECTIVE TISSUE GROWTH FACTOR: IMPLICATIONS FOR A ROLE OF MIRNAS IN MYOCARDIAL MATRIX REMODELING , 2013 .

[22]  Stanley Nattel,et al.  Atrial Tachycardia Remodeling of Pulmonary Vein Cardiomyocytes: Comparison With Left Atrium and Potential Relation to Arrhythmogenesis , 2005, Circulation.

[23]  Richard P. Harvey,et al.  Molecular Pathway for the Localized Formation of the Sinoatrial Node , 2007, Circulation research.

[24]  A. Yndestad,et al.  Connective tissue growth factor--a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats. , 2004, Journal of molecular and cellular cardiology.

[25]  W. Park,et al.  Down‐regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma , 2008, Histopathology.

[26]  B. Lüderitz,et al.  Conduction disturbances and increased atrial vulnerability in Connexin40-deficient mice analyzed by transesophageal stimulation. , 1999, Circulation.

[27]  R. Hauer,et al.  Association of Human Connexin40 Gene Polymorphisms With Atrial Vulnerability as a Risk Factor for Idiopathic Atrial Fibrillation , 2004, Circulation research.

[28]  Stephen S. Cha,et al.  Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.

[29]  A. Gramolini,et al.  Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death , 2003, Nature.

[30]  Douglas L. Jones,et al.  Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. , 2006, The New England journal of medicine.

[31]  Peng-Sheng Chen,et al.  New concepts in atrial fibrillation: neural mechanisms and calcium dynamics. , 2009, Cardiology clinics.

[32]  Ramon Brugada,et al.  Short QT Syndrome and Atrial Fibrillation Caused by Mutation in KCNH2 , 2005, Journal of cardiovascular electrophysiology.

[33]  S. Nattel,et al.  Atrial Ischemia Promotes Atrial Fibrillation in Dogs , 2003, Circulation.

[34]  S. Nattel,et al.  Kir3-Based Inward Rectifier Potassium Current: Potential Role in Atrial Tachycardia Remodeling Effects on Atrial Repolarization and Arrhythmias , 2006, Circulation.

[35]  Levi A. Gheber,et al.  Molecular Basis for Zinc Transporter 1 Action as an Endogenous Inhibitor of L-type Calcium Channels* , 2009, The Journal of Biological Chemistry.

[36]  D. Clapham,et al.  Evaluation of the role of I(KACh) in atrial fibrillation using a mouse knockout model. , 2001, Journal of the American College of Cardiology.

[37]  F A Mathewson,et al.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.

[38]  U. Schotten,et al.  Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. , 2009, The Journal of clinical investigation.

[39]  Sander Verheule,et al.  Increased Vulnerability to Atrial Fibrillation in Transgenic Mice With Selective Atrial Fibrosis Caused by Overexpression of TGF-β1 , 2004, Circulation research.

[40]  D. Roden,et al.  Mutations in Sodium Channel β1- and β2-Subunits Associated With Atrial Fibrillation , 2009, Circulation. Arrhythmia and electrophysiology.

[41]  E. Benjamin,et al.  Genome-wide association studies of atrial fibrillation: past, present, and future. , 2011, Cardiovascular research.

[42]  Martin Bienengraeber,et al.  Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation. , 2006, Human molecular genetics.

[43]  Markus Grube,et al.  Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. , 2010, Journal of the American College of Cardiology.

[44]  J. Struck,et al.  Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI‐Atrial Fibrillation Trial , 2011, Journal of internal medicine.

[45]  A. Goette,et al.  Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. , 2009, Heart rhythm.

[46]  S. Nattel New ideas about atrial fibrillation 50 years on , 2002, Nature.

[47]  S. Bendahhou,et al.  Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. , 2004, American journal of human genetics.

[48]  José Jalife,et al.  Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation. , 2005, Biophysical journal.

[49]  U Ravens,et al.  Molecular Basis of Downregulation of G-Protein–Coupled Inward Rectifying K+ Current (IK,ACh) in Chronic Human Atrial Fibrillation: Decrease in GIRK4 mRNA Correlates With Reduced IK,ACh and Muscarinic Receptor–Mediated Shortening of Action Potentials , 2001, Circulation.

[50]  Hongmei Li,et al.  Neural Mechanisms of Paroxysmal Atrial Fibrillation and Paroxysmal Atrial Tachycardia in Ambulatory Canines , 2008, Circulation.

[51]  Michael J Ackerman,et al.  Prevalence of early-onset atrial fibrillation in congenital long QT syndrome. , 2008, Heart rhythm.

[52]  S. Nattel,et al.  Animal models for atrial fibrillation: clinical insights and scientific opportunities. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[53]  H. Yoshida,et al.  Genetic factors for lone atrial fibrillation. , 2007, International journal of molecular medicine.

[54]  K. Steinmeyer,et al.  Molecular mechanisms of early electrical remodeling: transcriptional downregulation of ion channel subunits reduces I(Ca,L) and I(to) in rapid atrial pacing in rabbits. , 2003, Journal of the American College of Cardiology.

[55]  S. Nattel,et al.  New antiarrhythmic drugs for treatment of atrial fibrillation , 2010, The Lancet.

[56]  W. Rottbauer,et al.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts , 2008, Nature.

[57]  Shuichi Kaneko,et al.  AGEs‐RAGE System Mediates Atrial Structural Remodeling in the Diabetic Rat , 2008, Journal of cardiovascular electrophysiology.

[58]  S. Hohnloser,et al.  Drug therapy , 2022 .

[59]  Jun Hu,et al.  Ryanodine Receptor-Mediated Ca2+ Events in Atrial Myocytes of Patients with Atrial Fibrillation , 2008, Cardiology.

[60]  J. Ruskin,et al.  Cardiac sodium channel mutation in atrial fibrillation. , 2008, Heart rhythm.

[61]  Fikret Er,et al.  Angiotensin II-induced changes of calcium sparks and ionic currents in human atrial myocytes: potential role for early remodeling in atrial fibrillation. , 2006, Cell calcium.

[62]  W. Shen,et al.  Epidemiology of atrial fibrillation: a current perspective. , 2007, Heart rhythm.

[63]  C. Guiraudon,et al.  Characterization of Sustained Atrial Tachycardia in Dogs with Rapid Ventricular Pacing‐Induced Heart Failure , 2003, Journal of cardiovascular electrophysiology.

[64]  Michael R. Rosen,et al.  Pathophysiology and Prevention of Atrial Fibrillation , 2001, Circulation.

[65]  D. Dobrev,et al.  The G Protein–Gated Potassium Current IK,ACh Is Constitutively Active in Patients With Chronic Atrial Fibrillation , 2005, Circulation.

[66]  E. Behr,et al.  The variation of the sarcolipin gene (SLN) in atrial fibrillation, long QT syndrome and sudden arrhythmic death syndrome. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[67]  A. Gori,et al.  Lone and secondary nonvalvular atrial fibrillation: role of a genetic susceptibility. , 2007, International journal of cardiology.

[68]  Eric Boerwinkle,et al.  Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry , 2009, Nature Genetics.

[69]  R F Bosch,et al.  Ionic mechanisms of electrical remodeling in human atrial fibrillation. , 1999, Cardiovascular research.

[70]  Toru Yamashita,et al.  Effects of a Highly Selective Acetylcholine-Activated K+ Channel Blocker on Experimental Atrial Fibrillation , 2011, Circulation. Arrhythmia and electrophysiology.

[71]  D. Roden,et al.  Novel KCNA5 mutation implicates tyrosine kinase signaling in human atrial fibrillation. , 2010, Heart rhythm.

[72]  V. Novack,et al.  Selective Molecular Potassium Channel Blockade Prevents Atrial Fibrillation , 2010, Circulation.

[73]  Jeffrey E. Thatcher,et al.  Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis , 2008, Proceedings of the National Academy of Sciences.

[74]  Takeshi Imamura,et al.  Arkadia amplifies TGF‐β superfamily signalling through degradation of Smad7 , 2003 .

[75]  G. Breithardt,et al.  Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability. , 2010, Heart rhythm.

[76]  Niels Voigt,et al.  Changes in I K, ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. , 2008, Cardiovascular research.

[77]  Yusong He,et al.  A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. , 2005, Biochemical and biophysical research communications.

[78]  L. Lai,et al.  Tachycardia of atrial myocytes induces collagen expression in atrial fibroblasts through transforming growth factor β1. , 2011, Cardiovascular research.

[79]  M. Rosen,et al.  Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation , 2005, Circulation.

[80]  A. Camm,et al.  Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[81]  J Clémenty,et al.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.

[82]  G. Hasenfuss,et al.  CaMKII-Dependent Diastolic SR Ca2+ Leak and Elevated Diastolic Ca2+ Levels in Right Atrial Myocardium of Patients With Atrial Fibrillation , 2010, Circulation research.

[83]  Keiko Tsuji,et al.  A novel SCN5A gain-of-function mutation M1875T associated with familial atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[84]  G. Lip,et al.  Lone atrial fibrillation: what do we know? , 2009, Heart.

[85]  A. Zima,et al.  Inositol‐1,4,5‐trisphosphate‐dependent Ca2+ signalling in cat atrial excitation–contraction coupling and arrhythmias , 2004, The Journal of physiology.

[86]  Michel Haïssaguerre,et al.  Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac Death , 2007, Circulation.

[87]  S. Nattel From guidelines to bench: implications of unresolved clinical issues for basic investigations of atrial fibrillation mechanisms. , 2011, The Canadian journal of cardiology.

[88]  A. Marks,et al.  The ryanodine receptor in cardiac physiology and disease. , 2010, Advances in pharmacology.

[89]  Stefan Wagner,et al.  Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. , 2010, Journal of the American College of Cardiology.

[90]  Robert Lemery,et al.  Gain-of-function mutation of Nav1.5 in atrial fibrillation enhances cellular excitability and lowers the threshold for action potential firing. , 2009, Biochemical and biophysical research communications.

[91]  H. Nakauchi,et al.  Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts. , 2010, The Journal of clinical investigation.

[92]  Thomas Meitinger,et al.  Common Variants in KCNN3 are Associated with Lone Atrial Fibrillation , 2010, Nature Genetics.

[93]  Wei Huang,et al.  KCNQ1 Gain-of-Function Mutation in Familial Atrial Fibrillation , 2003, Science.

[94]  D. Zipes,et al.  NO modulates autonomic effects on sinus discharge rate and AV nodal conduction in open-chest dogs. , 1997, The American journal of physiology.

[95]  Nolwenn Le Meur,et al.  Human Atrial Ion Channel and Transporter Subunit Gene-Expression Remodeling Associated With Valvular Heart Disease and Atrial Fibrillation , 2005, Circulation.

[96]  S. Hohnloser,et al.  Atrial Fibrillation and Congestive Heart Failure: Specific Considerations at the Intersection of Two Common and Important Cardiac Disease Sets , 2002, Journal of cardiovascular electrophysiology.

[97]  Zhao Zhang,et al.  Ablation of a Ca2+‐activated K+ channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation , 2009, The Journal of physiology.

[98]  S. Nattel,et al.  Mechanisms of Atrial Tachyarrhythmias Associated With Coronary Artery Occlusion in a Chronic Canine Model , 2011, Circulation.

[99]  Shenming Wang,et al.  Atrial Fibrillation Induces Myocardial Fibrosis Through Angiotensin II Type 1 Receptor–Specific Arkadia-Mediated Downregulation of Smad7 , 2011, Circulation research.

[100]  Masanori Hirose,et al.  Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2 channels to membrane sites. , 2007, Cardiovascular research.

[101]  S. Nattel,et al.  Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[102]  M. Allessie,et al.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.

[103]  T. Olson,et al.  A Common Polymorphism in SCN5A is Associated with Lone Atrial Fibrillation , 2007, Clinical pharmacology and therapeutics.

[104]  S. Nattel,et al.  Differential Behaviors of Atrial Versus Ventricular Fibroblasts: A Potential Role for Platelet-Derived Growth Factor in Atrial-Ventricular Remodeling Differences , 2008, Circulation.

[105]  E. Benjamin,et al.  Current perceptions of the epidemiology of atrial fibrillation. , 2009, Cardiology clinics.

[106]  I. V. Van Gelder,et al.  New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[107]  S. Nattel,et al.  Cellular Signaling Underlying Atrial Tachycardia Remodeling of L-type Calcium Current , 2008, Circulation research.

[108]  J. Nerbonne,et al.  Atrial L-type Ca2+ currents and human atrial fibrillation. , 1999, Circulation research.

[109]  S. Nattel,et al.  Rate-dependence of atrial tachycardia effects on atrial refractoriness and atrial fibrillation maintenance. , 2009, Cardiovascular research.

[110]  R. Bosch,et al.  Atrial L-type Ca2+-channel, β-adrenoreceptor, and 5-hydroxytryptamine type 4 receptor mRNAs in human atrial fibrillation , 2001, Basic Research in Cardiology.

[111]  Niels Voigt,et al.  The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications. , 2011, Cardiovascular research.

[112]  L. Hunyady,et al.  Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. , 2006, Molecular endocrinology.

[113]  Maurits A. Allessie,et al.  Reverse Structural and Gap-Junctional Remodeling After Prolonged Atrial Fibrillation in the Goat , 2003, Circulation.

[114]  Jan D'hooge,et al.  Ultrastructural and Functional Remodeling of the Coupling Between Ca2+ Influx and Sarcoplasmic Reticulum Ca2+ Release in Right Atrial Myocytes From Experimental Persistent Atrial Fibrillation , 2009, Circulation research.

[115]  Shien-Fong Lin,et al.  Intrinsic Cardiac Nerve Activity and Paroxysmal Atrial Tachyarrhythmia in Ambulatory Dogs , 2010, Circulation.

[116]  C. Vahl,et al.  Human Cardiac Inwardly-Rectifying K+ Channel Kir2.1b Is Inhibited by Direct Protein Kinase C-Dependent Regulation in Human Isolated Cardiomyocytes and in an Expression System , 2002, Circulation.

[117]  V. Shusterman,et al.  Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-{alpha}. , 2005, American journal of physiology. Heart and circulatory physiology.

[118]  D. Levy,et al.  Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop , 2009, Circulation.

[119]  U Ravens,et al.  Atrial Fibrillation Is Associated With Increased Activity of , 2022 .

[120]  Leif Hove-Madsen,et al.  Atrial Fibrillation Is Associated With Increased Spontaneous Calcium Release From the Sarcoplasmic Reticulum in Human Atrial Myocytes , 2004, Circulation.

[121]  L. J. Leon,et al.  Cholinergic Atrial Fibrillation in a Computer Model of a Two-Dimensional Sheet of Canine Atrial Cells With Realistic Ionic Properties , 2002, Circulation research.

[122]  Thomas Jespersen,et al.  Inhibition of Small-Conductance Ca2+-Activated K+ Channels Terminates and Protects Against Atrial Fibrillation , 2010, Circulation. Arrhythmia and electrophysiology.

[123]  S. Nattel,et al.  Changes in Connexin Expression and the Atrial Fibrillation Substrate in Congestive Heart Failure , 2009, Circulation research.

[124]  D. Dobrev,et al.  Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation. , 2007, Cardiovascular research.

[125]  S Nattel,et al.  Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. , 1999, Circulation research.

[126]  Mark I McCarthy,et al.  Genome-wide association studies: past, present and future. , 2008, Human molecular genetics.

[127]  B. Stambler,et al.  Mapping of Atrial Activation During Sustained Atrial Fibrillation in Dogs with Rapid Ventricular Pacing Induced Heart Failure: Evidence for a Role of Driver Regions , 2005, Journal of cardiovascular electrophysiology.

[128]  Jeffrey L. Anderson,et al.  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. , 2005, JAMA.

[129]  Ursula Ravens,et al.  Molecular Determinants of Altered Ca2+ Handling in Human Chronic Atrial Fibrillation , 2006, Circulation.

[130]  Richard P Harvey,et al.  Pitx2c and Nkx2-5 Are Required for the Formation and Identity of the Pulmonary Myocardium , 2007, Circulation research.

[131]  Yanjie Lu,et al.  MicroRNAs and atrial fibrillation: new fundamentals. , 2011, Cardiovascular research.

[132]  S. Kauppinen,et al.  Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. , 2010, The Journal of clinical investigation.

[133]  S. Nattel,et al.  Atrial fibrillation-associated minK38G/S polymorphism modulates delayed rectifier current and membrane localization. , 2005, Cardiovascular research.

[134]  S Nattel,et al.  Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. , 1997, Circulation research.

[135]  F. Mohr,et al.  Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides , 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.

[136]  Stanley Nattel,et al.  Calcium-Handling Abnormalities Underlying Atrial Arrhythmogenesis and Contractile Dysfunction in Dogs With Congestive Heart Failure , 2008, Circulation. Arrhythmia and electrophysiology.

[137]  J. Svendsen,et al.  Mutations in sodium channel β-subunit SCN3B are associated with early-onset lone atrial fibrillation. , 2011, Cardiovascular research.

[138]  K. Pietras,et al.  Platelet-Derived Growth Factor D Induces Cardiac Fibrosis and Proliferation of Vascular Smooth Muscle Cells in Heart-Specific Transgenic Mice , 2005, Circulation research.

[139]  D. Maclennan,et al.  Store overload‐induced Ca2+ release as a triggering mechanism for CPVT and MH episodes caused by mutations in RYR and CASQ genes , 2009, The Journal of physiology.

[140]  J. Tolstrup,et al.  Alcohol Consumption and Risk of Atrial Fibrillation in Men and Women: The Copenhagen City Heart Study , 2005, Circulation.

[141]  José Jalife,et al.  Frequency-Dependent Breakdown of Wave Propagation Into Fibrillatory Conduction Across the Pectinate Muscle Network in the Isolated Sheep Right Atrium , 2002, Circulation research.

[142]  Nolwenn Le Meur,et al.  Contrasting Gene Expression Profiles in Two Canine Models of Atrial Fibrillation , 2007, Circulation research.

[143]  M. Allessie,et al.  Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. , 2009, Journal of molecular and cellular cardiology.

[144]  S Nattel,et al.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. , 1999, Circulation.

[145]  F. Sofi,et al.  Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation. , 2006, European heart journal.

[146]  A. Toker,et al.  Lacrimal gland PKC isoforms are differentially involved in agonist-induced protein secretion. , 1997, The American journal of physiology.